The clinical and biochemical observations in a patient with a mild form of Ehlers-Danlos syndrome (EDS) type IV are described. The patient's skin fibroblasts produced markedly diminished amounts of type M collagen. SDSpolyacrylamide gel electrophoresis of collagens produced by cells obtained from other, non-cutaneous tissues showed two forms of collagen al(a) chains, a normal and a slow migrating, mutant form. Further analysis confirmed that the type III collagen molecules containing mutant a chains which were overmodified had a lower thermal stability and were poorly secreted into the extracellular medium.
Ehlers-Danlos syndrome (EDS)
Type III collagen is an homotrimeric molecule containing three identical protein chains encoded by a single complex gene. The protein is synthesised as a precursor which undergoes a series of post-translational modifications. The most notable of these are hydroxylation of specific proline and lysine residues and glycosylation of some of the hydroxylysines thus formed. From the random association of three a chains into trimers, it follows that a mutation in one of the COL3A1 alleles will affect 7/8 of the completed type III collagen molecules. '7 This paper reports clinical data and biochemical analysis of a patient with a mild form of EDS IV, using conventional skin fibroblasts and cells derived from non-cutaneous tissues such as artery, vein, and peritoneum. The patient is heterozygous for a structural mutation in the collagen helix close to the Cpropeptide of the collagen type III molecule.
Case report
The proband is a 54 year old woman with a lifetime history of easy bruising and recurrent bleeding and haematomas. She had suffered from varicose veins on the lower legs and from attacks of superficial phlebitis for several years. On three occasions her right shoulder had dislocated spontaneously. She was the fourth of seven sibs. Family history was otherwise unremarkable.
Clinical examination showed a short woman, below the 3rd centile for height (149 cm). Her facial features included prominent eyes with blueish sclerae, a pinched nose, and hypoplastic earlobes strongly suggestive of EDS IV (fig 1) . The skin was generally thin and showed a prominent venous network but was not hyperextensible. Several ecchymoses were visible on the legs and abdomen. The knees and shins showed atrophic scars and haemosiderin deposits at the sites of old haematomas. There was hyperextensibility of the large joints (especially the elbows and knees), but mobility of the small joints was within normal limits. The Beighton score was raised at 5/9. The heart was clinically normal.
The patient's most recent hospital admission, at the age of 54 years, followed an acute volvulus of the sigmoid colon which was successfully reduced endoscopically. Shortly afterwards she developed a perforated bowel. At laparotomy, a superficial perforation of the sigmoid colon was observed and a sigmoidectomy was performed. Biopsies from artery, vein, peritoneum, and skin were obtained and cell cultures were established from the different tissues.
Material and methods

HISTOLOGY
Samples for light microscopy were fixed in formaldehyde and stained with haematoxylin and eosin; those for electron microscopy were fixed with 4% glutaraldehyde, 0 1 mol/l cacodylate buffer, pH 7.4.
CELL CULTURE AND LABELLING
Cell cultures were established from explants of skin, artery, vein, and peritoneum. Control skin fibroblasts were obtained from a healthy adult. The cells were maintained in Optimem-1 (Gibco-BRL) supplemented with 2% Ultroser G (Gibco-BRL) and 5% fetal calf serum under standard conditions. Cells from passage 3 were grown on 50 mm plastic dishes and supplemented with 25 ig/ml ascorbic acid 24 hours before labelling.
Confluent cells were labelled for 20 hours in BME medium (FLOW laboratories) supplemented with 100 U/ml penicillin, 100 jg/ml streptomycin, 10 mmol/l Hepes, 50 ,.g/ml Paminopropionitrile, 25 gig/ml ascorbic acid, 5% dialysed fetal calf serum, and 1 jCi/ml 14C-proline. In some experiments incubation was at temperatures below 37°C and in others 0-3 mmol/l aa'-dipyridyl was added to the labelling medium.
After labelling, the medium was removed and proteinase inhibitors were added (50 1Lg/ ml phenylmethylsulphonylfluoride (PMSF), 50 jg/ml N-ethylmaleimide (NEM), and 10 mmol/l EDTA final concentration). The cells were washed several times with phosphate buffered saline (PBS) and trypsinised from the dish. The pelleted cells were lysed at 4'C for one hour with 05 mol/l acetic acid containing 0-5% Triton X-100.
After aa'-dipyridyl labelling, cells were lysed with PBS (phosphate buffered saline) containing 0-5% Triton X-100 and proteinase inhibitors. The For the analysis of procollagens, aliquots were lyophilised and redissolved in electrophoresis sample buffer containing 2 mol/l urea and 1% P-mercaptoethanol.
To convert procollagen to collagen the alcohol precipitates were digested with pepsin (50 gtg/ml, Boehringer) for six hours at 15°C. The pepsin was inhibited with pepstatin (0-05 ig/ml, Boehringer), the sample lyophilised, and redissolved in electrophoresis buffer without f3-mercaptoethanol.
GEL ELECTROPHORESIS
Samples were analysed by 5% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with the Laemmli buffer system'8 containing 2 mol/l urea. Type III collagen was analysed under non-reducing conditions (as disulphide bonded trimers) and after delayed reduction (as monomers).'9 After electrophoresis, the gels were processed for fluorography2" and exposed to Kodak X-OMAT S films.
For two dimensional mapping, a chains were first separated by delayed reduction on SDS gels, then gel lanes were cut out and treated with cyanogen bromide (CNBr) in 70% formic acid for three hours at room temperature. The gel slices were re-equilibrated in gel sample buffer, embedded in 5% stacking gel, and electrophoresed in the second dimension on a 10% SDS-polyacrylamide gel. Radioactively labelled peptides were visualised by fluorography. IMMUNOPRECIPITATION a measure of the entity of disruption of the triple helical domain.1122 Collagens were dissolved in 0 1 mol/l Tris-HGl, pH 7 5, 0 4 mol/l NaCi overnight at 4°C. The temperature of the collagen solution was increased linearly from 33°C to 44°C at a rate of 15°C/hour. At temperature intervals of 1°C, aliquots were removed and digested with 100 ptg/ml trypsin for two minutes at 20°C then 100 jtg/ml ovomucoid trypsin inhibitor was added.
The reaction products were analysed by SDS-polyacrylamide gel electrophoresis with delayed reduction. 
Results
HISTOLOGY
Various tissues from the patient were examined by light and electron microscopy. In the skin, connective tissue fibres were sparse and collagen fibrils were irregular with marked variability in the diameter (fig 2) . Some fibroblasts showed a dilatation of the rough endoplasmic reticulum.
In the distended bowel, the mucous membrane and the muscularis mucosae were relatively well preserved. The submucosa was generally thin with few fibroblasts and irregular, fragmented collagen fibres.
In several areas the deep muscle layer showed inflammatory infiltration and intramural bleeding. In other sites the muscularis was narrow and disrupted by distension. There was serositis and mesothelial proliferation. There were striking vascular malformations and telangiectasias.
ANALYSIS OF PROCOLLAGENS AND COLLAGENS
Analysis of unreduced pepsin treated collagens secreted into the medium by the patient's skin fibroblasts showed barely visible amounts of type III collagen. In contrast, cells from the 
other tissues (peritoneum, vein, and artery) showed higher but variable amounts of type III collagen ( fig 3A) . After delayed reduction a doublet consisting of normal and slow migrating ocl'(III) chains was clearly visible in the medium of cells from non-cutaneous tissues and faintly detectable in that from the skin fibroblasts ( fig 3B) . Examination of the cellular proteins showed that a significant amount of the slow migrating component was retained intracellularly (data not shown). Two forms of type III pro a chains were also observed after separation of procollagens under reducing conditions ( fig 3C) .
To prove the slow migrating a chains were from type III collagen, the pepsinised collagens were separated unreduced on a first dimension gel and in the second dimension after in situ reduction with P-mercaptoetha- 
MELTING CURVE
Exposure of collagen molecules to increasing temperatures and digestion with trypsin showed that molecules containing the mutant al'(III) chains were degraded at 38'C, 2°C lower than the normal type III collagen molecules from the patient and from a normal control ( fig 5) .
CYANOGEN BROMIDE (CNBR) DIGESTION OF THE TWO COLLAGEN TYPE III COMPONENTS
Two dimensional cyanogen bromide mapping of the unreduced type III collagen from the patient showed quite a normal peptide pattern although there were some differences, especially in the ca (III) CB5 (fig 6) . Mapping of the type III collagen components, separated by electrophoresis with delayed reduction, showed a triplet of spots in the CB5, CB9 region. The patient's normal al(III) chain gave a single spot for both peptides comparable to control sample whereas the slow migrating al'(III) chains had a doublet of spots for these peptides, both migrating slower than the normal peptides. The partial cleavage products higher up the gel were also tilted, showing the presence of both normal and slow migrating components. group has survived until her mi ing serious vascular or while patients with clas vascular ruptures at a rel must, therefore, be consi variant of the disorder. 
